New use for once-cursed drug Thalidomide?

Apr 04, 2010

Thalidomide, the sedative blamed for tragic birth defects half a century ago, treated a rare inherited blood disorder, according to lab experiments reported on Sunday.

Around one person in 10,000 has a disorder called hereditary haemorrhagic telangiectasia, or HHT, which causes frequent, hard-to-treat nosebleeds.

French doctors, experimenting on mice genetically engineered to have HHT, found that reduced the risk of haemorrhage and stabilised blood vessels.

The drug works by boosting a protein called PDGF-B, the team from the National Institute of Health and Medical Research (Inserm) report in the journal Nature Medicine.

The work is experimental, aimed at showing the pathways by which HHT could be cured.

Thalidomide was sold between 1957 and 1961 until it was found that pregnant women who took the drug for morning sickness were at high risk of having a child missing a limb or having stunted arms.

More than 10,000 babies, especially in Germany, Britain, Australia and Canada, were affected.

The scandal led to a tightening of vetting procedures for drug prototypes and scrutiny of claims by pharmaceutical giants.

Thalidomide remains outlawed for general distribution.

In recent years, though, interest in it has revived as a research tool but also as a treatment for a form of cancer called and side-effects from . It is prescribed to patients only in very tightly-controlled conditions.

Explore further: Oregon Medicaid targets expensive hepatitis drug

add to favorites email to friend print save as pdf

Related Stories

Japan team uncovers thalidomide mystery

Mar 12, 2010

Japanese scientists have uncovered how thalidomide led to deformities in children born to mothers taking the drug in the 1950s and 1960s, according to a study released Friday.

New insights into thalidomide-birth defect episode

Nov 10, 2008

Scientists in Germany have discovered why the medication thalidomide appeared safe in animal tests before going on the market 50 years ago, only to cause perhaps the most extensive outbreak of drug-induced birth defects in ...

Solving the 50-year-old puzzle of thalidomide

Nov 17, 2009

Research into the controversial drug thalidomide reveals that the mechanism through which the drug causes limb defects is the same process which causes it to damage internal organs and other tissues. The article, published ...

Japan may regulate thalidomide

Jun 13, 2006

Doctors in Japan will be required to register patients who are using the drug thalidomide under proposed regulations, the Japan Times reported.

Thalidomide film to air in Germany

May 19, 2007

A film about the drug thalidomide, which caused thousands of children to be born disabled, will air on German television.

Recommended for you

FDA to start regulating lab-developed tests

16 hours ago

(AP)—The Food and Drug Administration announced Thursday it will begin regulating laboratory-developed tests, a growing class of medical diagnostics that have never before been subject to federal oversight.

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

User comments : 0